158 related articles for article (PubMed ID: 21423200)
1. Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.
Nguyen-Pham TN; Lim MS; Nguyen TA; Lee YK; Jin CJ; Lee HJ; Hong CY; Ahn JS; Yang DH; Kim YK; Chung IJ; Park BC; Kim HJ; Lee JJ
Cell Mol Immunol; 2011 Jul; 8(4):341-7. PubMed ID: 21423200
[TBL] [Abstract][Full Text] [Related]
2. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma arms human dendritic cells to perform multiple effector functions.
Frasca L; Nasso M; Spensieri F; Fedele G; Palazzo R; Malavasi F; Ausiello CM
J Immunol; 2008 Feb; 180(3):1471-81. PubMed ID: 18209042
[TBL] [Abstract][Full Text] [Related]
4. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.
Boullart AC; Aarntzen EH; Verdijk P; Jacobs JF; Schuurhuis DH; Benitez-Ribas D; Schreibelt G; van de Rakt MW; Scharenborg NM; de Boer A; Kramer M; Figdor CG; Punt CJ; Adema GJ; de Vries IJ
Cancer Immunol Immunother; 2008 Nov; 57(11):1589-97. PubMed ID: 18322684
[TBL] [Abstract][Full Text] [Related]
5. Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production.
Dauer M; Lam V; Arnold H; Junkmann J; Kiefl R; Bauer C; Schnurr M; Endres S; Eigler A
J Immunol Methods; 2008 Sep; 337(2):97-105. PubMed ID: 18657542
[TBL] [Abstract][Full Text] [Related]
6. Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors.
Lehner M; Morhart P; Stilper A; Petermann D; Weller P; Stachel D; Holter W
J Immunother; 2007 Apr; 30(3):312-22. PubMed ID: 17414322
[TBL] [Abstract][Full Text] [Related]
7. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
[TBL] [Abstract][Full Text] [Related]
8. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
9. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists.
Roses RE; Xu S; Xu M; Koldovsky U; Koski G; Czerniecki BJ
J Immunol; 2008 Oct; 181(7):5120-7. PubMed ID: 18802116
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
Tada H; Aiba S; Shibata K; Ohteki T; Takada H
Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
[TBL] [Abstract][Full Text] [Related]
11. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
12. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
14. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
[TBL] [Abstract][Full Text] [Related]
15. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
Krumbiegel D; Zepp F; Meyer CU
Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
[TBL] [Abstract][Full Text] [Related]
16. Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells.
Bax M; van Vliet SJ; Litjens M; García-Vallejo JJ; van Kooyk Y
PLoS One; 2009 Sep; 4(9):e6987. PubMed ID: 19750015
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of radiolabelled human dendritic cells injected by various routes.
Quillien V; Moisan A; Carsin A; Lesimple T; Lefeuvre C; Adamski H; Bertho N; Devillers A; Leberre C; Toujas L
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):731-41. PubMed ID: 15924229
[TBL] [Abstract][Full Text] [Related]
18. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
He M; Soni B; Schwalie PC; Hüsser T; Waltzinger C; De Silva D; Prinz Y; Krümpelmann L; Calabro S; Matos I; Trumpfheller C; Bacac M; Umaña P; Levesque MP; Dummer R; van den Broek M; Gasser S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688559
[TBL] [Abstract][Full Text] [Related]
19. Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function.
Trepiakas R; Pedersen AE; Met O; Svane IM
Vaccine; 2009 Apr; 27(16):2213-9. PubMed ID: 19428835
[TBL] [Abstract][Full Text] [Related]
20. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
